04/11/2016
https://www.congress.gov...
"I subsequently introduced S. 4071, the Helping Experts Accelerate Rare Treatments Act of 2022 with Senator Tim Scott."
"the financial realities of developing these new agents remain very challenging."
"key among these challenges is reaching agreement with regulators about determining the appropriate efficacy endpoints to support approval of innovative medicines for rare diseases."
"antimicrobial resistance is a public health crisis, and no single solution is going to fix the problem."